Company Filing History:
Years Active: 2020-2022
Title: Jinyoung Kang: Innovator in Nanoparticle Technology
Introduction
Jinyoung Kang is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of nanoparticle technology, particularly in the development of innovative delivery systems for therapeutic applications. With a total of 2 patents, his work focuses on enhancing the efficiency of drug delivery mechanisms.
Latest Patents
One of Jinyoung Kang's latest patents involves fusogenic liposome-coated porous silicon nanoparticles. This invention describes a system designed for high loading efficiency of anionic payloads, including small molecules, dyes, and nucleic acids. The technology allows for non-endocytic delivery of both hydrophilic and lipophilic payloads through membrane fusion. The liposome coating can be modified with targeting peptides or antibodies, utilizing covalent binding chemistry with functionalized poly(ethylene glycol). This innovative approach enables the transfer of surface moieties to cellular membranes via fusogenic uptake, making it applicable in the treatment of various diseases by delivering encapsulated payloads.
Career Highlights
Jinyoung Kang is affiliated with the University of California, where he continues to advance research in nanoparticle technology. His work has garnered attention for its potential applications in medical treatments and drug delivery systems.
Collaborations
He collaborates with notable colleagues, including Michael J. Sailor and Byungji Kim, who contribute to the research and development of his innovative technologies.
Conclusion
Jinyoung Kang's contributions to nanoparticle technology exemplify the intersection of innovation and practical application in medicine. His work continues to pave the way for advancements in drug delivery systems, showcasing the importance of research in improving healthcare outcomes.